Search

everythinglearnresearchcommunity

for

Search:↓

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

People with lupus in Mauritius face many challenges and need more support and understanding.

Upadacitinib effectively treats psoriasis and lichen planus together.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Radiation therapy can worsen Discoid Lupus Erythematosus.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

A man with severe leprosy developed painless ulcers and numbness, treated successfully with multiple drugs and vitamins.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Brain fog in lupus is common, worrying, and often not treated properly.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Hair products don't affect lupus development or severity.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.